Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists disprove two tenets of common leukemia

11.02.2005


Scientists at the Institute for Medical Research at North Shore-LIJ have made a discovery that refutes two longstanding beliefs about the most common leukemia in the western hemisphere. Due to the relatively slow disease progression of chronic lymphocytic leukemia (CLL), doctors thought it was caused by a gradual accumulation of leukemia cells that could not die. The new findings, published online today in the Journal of Clinical Investigation, prove the exact opposite. The study will appear in the journal’s March 2005 print issue.



For decades, doctors and scientists believed that CLL was a static disease of long-lived white blood cells (lymphocytes) -- that the leukemia cells were both immortal and born at a slow rate, causing the slow rise in cell count over time. But researchers had been unable to find any problems with the leukemia cells’ process of cell suicide, called apoptosis, a normal part of the cell life cycle for which all cells are programmed. This was a hint that perhaps the leukemia cells were not immortal. Using a clever study design that required subjects only to drink water and give blood samples, the research team, led by Nicholas Chiorazzi, MD, director and CEO of the Institute for Medical Research, found that the leukemia cells are born at a fast rate and do indeed die. The slow rise in the cell count over time can be attributed to the difference between the birth and death rates of the cells, according to the study.

The scientists also found that there appeared to be a connection between poorer patient outcomes and the faster birth rates of the leukemia cells, regardless of the rate of cell death. "This particular finding may prove helpful in identifying patients who are at risk for worsening disease in advance of showing any clinical signs of deterioration," said Dr. Chiorazzi. He cautioned, however, that additional research is needed to establish its potential in guiding prognostic and treatment decisions. The study was small, examining 19 CLL patients.


A larger trial is already underway to gain greater insights into the correlation and its potential clinical applications. The multicenter study is being led by Kanti Rai, MD, associate investigator with the Institute for Medical Research, chief of the Division of Hematology-Oncology at Long Island Jewish (LIJ) Medical Center and a world-renowned expert on CLL. More than 25 years ago, Dr. Rai developed a staging system for CLL that is still used today. Tahrun Wasil, MD, another well-known attending hematologist-oncologist at LIJ, is co-leading the trial with Dr. Rai. The study is being conducted in conjunction with the CLL Research Consortium (CRC), a multi-institutional project funded by the National Institutes of Health. The CRC includes LIJ Medical Center, University of California at San Diego, M.D. Anderson Cancer Center, Ohio State University, Johns Hopkins University, Dana Farber Cancer Institute, Mayo Clinic, and several sites that perform laboratory work alone, including the Burnham Institute and Sydney Kimmel Cancer Center.

To test his theory that leukemia cells were not immortal, Dr. Chiorazzi used "heavy water" to track cell production. Heavy water is simply water that weighs more at the molecular level than normal. Among its many uses in the body, water gets incorporated into everyone’s DNA. When a cell divides into two, the new cell gets an exact copy of the DNA from the original cell, so the incorporated heavy water serves as a tag that allows scientists to track the birth of new cells.

The researchers gave individuals with CLL a small dose of heavy water -- about two ounces -- every day over the course of 12 weeks, enough time for the cells to incorporate a sufficient amount into their DNA. From blood samples, they calculated the birth and death rates of leukemia cells. They found that CLL is very much a dynamic process composed of mortal cells that proliferate and die, often with a high turnover, and not a static disease in which leukemia cells slowly build up because they cannot die, as previously thought.

Christina Verni | EurekAlert!
Further information:
http://www.nshs.edu

More articles from Health and Medicine:

nachricht Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania

nachricht The strange double life of Dab2
10.01.2017 | University of Miami Miller School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

Im Focus: Newly proposed reference datasets improve weather satellite data quality

UMD, NOAA collaboration demonstrates suitability of in-orbit datasets for weather satellite calibration

"Traffic and weather, together on the hour!" blasts your local radio station, while your smartphone knows the weather halfway across the world. A network of...

Im Focus: Repairing defects in fiber-reinforced plastics more efficiently

Fiber-reinforced plastics (FRP) are frequently used in the aeronautic and automobile industry. However, the repair of workpieces made of these composite materials is often less profitable than exchanging the part. In order to increase the lifetime of FRP parts and to make them more eco-efficient, the Laser Zentrum Hannover e.V. (LZH) and the Apodius GmbH want to combine a new measuring device for fiber layer orientation with an innovative laser-based repair process.

Defects in FRP pieces may be production or operation-related. Whether or not repair is cost-effective depends on the geometry of the defective area, the tools...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Solar Collectors from Ultra-High Performance Concrete Combine Energy Efficiency and Aesthetics

16.01.2017 | Trade Fair News

3D scans for the automotive industry

16.01.2017 | Automotive Engineering

Nanoparticle Exposure Can Awaken Dormant Viruses in the Lungs

16.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>